Cardiogenic shock is a life-threatening condition in which your heart is suddenly unable to pump as much blood as your body needs. It is a complex condition that requires immediate intervention.
On a moment’s notice, our Cardiogenic Shock (CS) Program brings together experts in advanced cardiac care, including critical care, heart failure, interventional cardiology and cardiac surgery to care for these patients with early optimization of advanced treatment.
“Having a multidisciplinary team of advanced heart specialists involved in every phase of a cardiogenic shock patient’s care means we are able to identify and implement the most appropriate treatment in the shortest amount of time,” says cardiologist On Chen, MD, Director of the Cardiogenic Shock Program and Director of the Cardiac Intensive Care Unit. “By pooling our expertise, we are improving the outcomes for some of our sickest patients with early recognition and advanced treatment.”
"The Cardiogenic Shock Program is one of only a few such programs available nationwide. “If a provider thinks a patient may have developed cardiogenic shock, Stony Brook’s Cardiogenic Shock Team, quickly and collaboratively responds to provide urgent recommendations and facilitate transfers from hospitals throughout the region for patients who need the expertise and resources that are uniquely available at Stony Brook,” added Edlira Tam, DO, and Co-Director of the Cardiogenic Shock Program and Co-Director of the Ventricular Assist Device (VAD)Program.
Here's some of the ways we are raising CS outcomes:
- Partnership with the New York Cardiogenic Shock Registry, where best practices and strategies are shared.
- A multidisciplinary team of heart specialists means we are ready to identify and implement the most appropriate treatment in the shortest amount of time.
- The CS Team is equipped to provide advanced treatment, as needed, including extracorporeal membrane oxygenation (ECMO), mechanical circulatory support devices and 24/7 surgical support.
- If a provider thinks a patient has developed CS, the Team quickly responds to provide guidance and facilitates transfers from hospitals throughout the region.
to transfer a
“While a severe heart attack is the most frequent cause of cardiogenic shock, heart failure, heart valve disorder, heart rhythm disturbance, infection, blood clots in the lungs and complications from surgery are among other causes of cardiogenic shock,” noted Marc Goldschmidt, MD, Director of the Heart Failure and Cardiomyopathy Center at Stony Brook Medicine.
Patients presenting with heart attacks complicated by shock have the highest mortality rates. Immediate care employing state of the art strategies optimizes the chances for meaningful survival,” notes Robert Pyo, MD, Director of Interventional Cardiology. “Treatment includes medical therapy for initial stabilization, then appropriate triage for advanced therapy that includes stent procedures to optimally restore circulation and use of mechanical heart pumps for sustained stability and recovery.”
When every minute counts, leading-edge protocols and technology in the hands of our expert cardiogenic shock team facilitate state of the art critical lifesaving care. “We have 24/7 access to surgical procedures, including coronary artery bypass surgery, surgery to repair an injury to the heart valves and the aorta and ventricular assist device support,” says Henry Tannous, MD, General T.F Cheng Chair, Cardiothoracic Surgery, Renaissance School of Medicine at Stony Brook University and Co-Director, Heart Institute.
“When patients are so sick that they need complete support of the circulatory system, early escalation and placement on extracorporeal membrane oxygenation (ECMO) is an option,” says Allison McLarty, MD, Director of the ECMO Program and Surgical Director of the VAD Program at the Heart Institute. “We have a team of highly trained cardiac specialists at the ready, day and night, for those situations.”
"Stony Brook leads the region in survival outcomes for patients with heart attacks and heart failure, evidence of our clinical abilities and our desire to explore new approaches and improve the care of cardiac patients throughout Long Island. Partnering with the New York Cardiogenic Shock Registry, establishing novel rapid-response diagnostic and treatment protocols, and providing our data to be analyzed for optimal clinical outcomes are the hallmark of the cutting-edge hospitals participating in the registry,” concluded Hal Skopicki, MD, PhD, Ambassador Charles A. Gargano Chair, Cardiology Renaissance School of Medicine at Stony Brook University and Co-Director, of the Stony Brook Heart Institute.